Reven Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Reven Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Revascularization of Stenosed Vessels Using Optimized Treatment of Rejuveinix for Reversing Endothelial Dysfunction (NCT03041259) | Reven Pharmaceuticals, Inc. | 2020-01-01 |
| A Safety and Tolerability Study of RJX Drug Product in Healthy Participants (NCT03680105) | Reven Pharmaceuticals, Inc. | 2018-08-24 |
Track Reven Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.